Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.745
-0.065 (-2.31%)
May 19, 2026, 12:45 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $495.79 million as of May 19, 2026. Its market cap has increased by 131.17% in one year.
Market Cap
495.79M
Enterprise Value
486.55M
1-Year Change
131.17%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $495.79M, a decrease of -69.53%. That is a compound annual growth rate of -28.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 507.54M | -17.38% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 524.19M |
| Rigel Pharmaceuticals | 524.16M |
| XOMA Royalty | 522.96M |
| Cabaletta Bio | 516.87M |
| AgomAb Therapeutics NV | 508.24M |
| Forte Biosciences | 506.72M |
| ProKidney | 487.67M |
| Prothena Corporation | 486.89M |